Willow Biosciences

(TSX) WLLW

Current PriceN/A

Market CapN/A

Since IPO (2019)-99%

5 Year-97%

1 Year+13%

1 Month-3%

Willow Biosciences Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$5.34M

Net Income (TTM)

$2.09M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

WLLW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Willow Biosciences

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Mark Hodgson

Website

atlas-corp.ca

Headquarters

Calgary, AB T2R 0Y6, CA

WLLW Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

-64%

Net Income Margin

-23%

Return on Equity

-9%

Return on Capital

-8%

Return on Assets

-3%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$3.28M

Operating Income

$5.99M

EBITDA

$4.54M

Operating Cash Flow

$3.72M

Capital Expenditure

$20.00K

Free Cash Flow

$3.74M

Cash & ST Invst.

$353.00K

Total Debt

$1.97M

Willow Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2025YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$370.00K

+121.9%

EBITDA

$891.00K

+18.8%

Quarterly Fundamentals

Name

Q2 2025YOY CHG

Net Cash

$29.22M

+3473.7%

Accounts Receivable

$86.00K

+561.5%

Inventory

$0.00

-100.0%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$0.00

-100.0%

Return on Assets

-2.85%

N/A

Return on Invested Capital

-8.13%

N/A

Free Cash Flow

$1.88M

-156.5%

Operating Cash Flow

$1.88M

-156.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7363.32-0.01%

^DJIDJI

^DJIDJI$49430.22-0.00%

^IXICNASDAQ

^IXICNASDAQ$25924.42-0.01%

BTCBitcoin

BTCBitcoin$76342.00-0.02%

AAPLAAPL

AAPLAAPL$295.80-0.01%

AMZNAMZN

AMZNAMZN$263.40-0.00%

GOOGGOOG

GOOGGOOG$395.06+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.11-0.08%

TET1 Energy Inc.

TET1 Energy Inc.$6.17-0.12%

NOWLGraniteShares ETF Trust - GraniteShares 2x Long Now Daily ETF

NOWLGraniteShares ETF Trust - GraniteShares 2x Long Now Daily ETF$5.40+0.04%

INTCIntel

INTCIntel$105.23-0.03%

POETPoet Technologies

POETPoet Technologies$12.48-0.12%

NOKNokia

NOKNokia$13.40-0.02%

NVDANvidia

NVDANvidia$221.28-0.00%

Questions About WLLW

What is the current price of Willow Biosciences?

Willow Biosciences is trading at N/A per share.

What is the 52-week range for Willow Biosciences?

Over the past 52 weeks, Willow Biosciences has traded between N/A and N/A.

How much debt does Willow Biosciences have?

As of the most recent reporting period, Willow Biosciences reported total debt of N/A.

How much cash does Willow Biosciences have on hand?

Willow Biosciences reported $26.68M in cash and cash equivalents in its most recent financial results.

What is Willow Biosciences’s dividend yield?

Willow Biosciences does not currently have a dividend yield.

Willow Biosciences

Willow Biosciences Financials at a Glance

WLLW News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Willow Biosciences

WLLW Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Willow Biosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About WLLW

What is the current price of Willow Biosciences?

What is the 52-week range for Willow Biosciences?

How much debt does Willow Biosciences have?

How much cash does Willow Biosciences have on hand?

What is Willow Biosciences’s dividend yield?

Premium Investing Services